Advances in ATTR-CM: Evolving Diagnostics and Therapeutics
from Heart Matters
Guest: Kevin Alexander In the past decade, significant strides have been made in diagnosing and treating patients with transthyretin amyloid cardiomyopathy (ATTR-CM). Increased disease awareness, non-invasive diagnostic tools like scintigraphy, and AI-assisted screening have led to earlier detection and improved outcomes. Learn more with Dr. Kevin Alexander, an Assistant Professor of Cardiovascular Medicine at the Stanford University School of Medicine.
Embed this episode
No transcript yet.
Frequently asked questions
How long is this episode of Heart Matters?
This episode is 4 minutes long.
When was this Heart Matters episode published?
This episode was published on January 20, 2026.
Can I download this Heart Matters episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.